{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-347911","form_type":"8-K","ticker":"PYXS","cik":"0001782223","company_name":"Pyxis Oncology, Inc.","filed_at":"2026-08-13T11:42:49+00:00","discovered_at":"2026-08-13T11:45:13.375986+00:00","generated_at":"2026-08-13T11:45:18.875869+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Pyxis Oncology Q2 net loss $25.3M; $50M private placement extends cash runway into Q2 2027","bullets":["Net loss $25.3M ($0.40/share) vs $18.4M ($0.30) in Q2 2025; R&D $16.1M, G&A $9.9M.","Completed July 2, 2026 private placement: ~$50M upfront gross, up to $64M more if warrants exercised.","Cash, equivalents, restricted cash, and short-term investments $34.5M at June 30, 2026; runway into Q2 2027.","MICVO Phase 1 monotherapy update in 2L+ R/M HNSCC expected Fall 2026; pembrolizumab combo update Q4 2026.","Interim CEO Tom Civik cites financing and clinical execution; shares outstanding 83.4M as of Aug 12, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-347911","json":"https://secwatch.observer/filing/0001193125-26-347911.json","markdown":"https://secwatch.observer/filing/0001193125-26-347911.md","text":"https://secwatch.observer/filing/0001193125-26-347911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/0001193125-26-347911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1782223/000119312526347911/pyxs-20260813.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T11:45:18.875869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}